Dr. Villaume is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1031A 2nd Avenue South
Nashville, TN 37210Phone+1 615-322-5000
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2022 - 2026
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2020 - 2022
- Vanderbilt University School of MedicineClass of 2020
Certifications & Licensure
- TN State Medical License 2024 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 5 citationsSelective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes.Melissa A Fischer, Yuanbin Song, Maria P Arrate, Rana Gbyli, Matthew T Villaume
Haematologica. 2023-02-01 - 2 citationsThe delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T. Villaume, M. Pia Arrate, Haley E. Ramsey, Kathryn I. Sunthankar, Matthew T. Jenkins
Experimental Hematology. 2021-02-19 - 39 citationsVenetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies.Melissa A. Fischer, Sharon Friedlander, Maria Pia Arrate, Hua Chang, Agnieszka E. Gorska
Blood Advances. 2020-02-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: